JUST IN: World Health Organization says it is pausing its study on the anti-malaria drug hydroxychloroquine as part of its research into COVID-19 treatments. https://t.co/FgUj3Ue01h pic.twitter.com/y4figDEkVN

— ABC News (@ABC) May 25, 2020

“… 12:50 p.m.: WHO suspends hydroxychloroquine study
The World Health Organization said it would pause its study on the anti-malaria drug hydroxychloroquine as part of its ongoing research into COVID-19 treatments.

The move comes after a study was published in medical journal The Lancet that found coronavirus patients who took the drug were more likely to die or develop irregular heart rhythms. WHO said its executive group of the Solidarity Trial is reviewing data on its research into the drug while the pause goes into effect.

“The other arms of the trial are continuing,” Dr. Samba Sow, director general of the Center for Vaccine Development in Mali, said at a news conference. “This concern relates to the use of hydroxychloroquine and chloraquine in COVID-19.” …”